Fibrinogen synthesis is increased in cachectic patients with chronic heart failure

International Journal of Cardiology

Volumn 129, Issue 3, 2008, Pages 363-367

  Witte, Klaus K A ^d   Ford, Sarah J ^c   Preston, Tom ^a   Parker, John D ^b   Clark, Andrew L ^c  

^a SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF HULL   (United Kingdom)

^d NONE

Author keywords

Cachexia; Fibrinogen synthesis; Heart failure

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; PHENYLALANINE;

AGED; ANAMNESIS; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; CACHEXIA; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEART FAILURE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; WEIGHT REDUCTION; BIOSYNTHESIS; CHRONIC DISEASE; COMPARATIVE STUDY; COMPLICATION; METABOLISM;

AGED; CACHEXIA; CHRONIC DISEASE; FIBRINOGEN; HEART FAILURE; HUMANS; MALE;

EID: 52949109129     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.119     Document Type: Article

References (38)

1. Roubeno R., and Kehayias J.J. The meaning and measurement of lean body mass. Nutr Rev 49 (1991) 163-175
2. Anker S., Ponikowski P., Varney S., et al. Wasting as an independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
3. Anker S.D., Negassa A., Coats A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
4. Berry C., and Clark A.L. Catabolism in chronic heart failure. Eur Heart J 21 (2000) 521-532
5. Witte K.K.A., and Clark A.L. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol 85 suppl (2002) 23-31
6. Simonini A., Long C.E., Dudley G.A., Yue P., McElhinny J., and Massie B.M. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circulation Res 79 (1996) 128-136
7. Riley M., Elborn J.S., McKane W.R., Bell N., Stanford C.F., and Nicholls D.P. Resting energy expenditure in chronic cardiac failure. Clin Sci 80 (1991) 633-639
8. Poehlman E.T., Scheffers J., Gottlieb S.S., Fisher M.L., and Vaitekevicius P. Increased metabolic rate in patients with congestive heart failure. Ann Intern Med 121 (1994) 860-862
9. Obiesan T., Toth M.J., and Kendall D. Energy expenditure and symptom severity in men with heart failure. Am J Cardiol 77 (1996) 1250-1252
10. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
11. Zhao S.P., and Zeng L.H. Elevated plasma levels of tumour necrosis factor in chronic heart failure with cachexia. Int J Cardiol 58 (1997) 257-261
12. Falconer J.S., Fearon K.C.H., Plester C.E., Ross J.A., and Carter D.C. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219 (1994) 325-331
13. Staal van den Brekel A.J., Dentener M.A., Schols A.M.W.J., Buurman W.A., and Wouter E.F.M. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13 (1995) 2600-2605
14. Wigmore S.J., Plester C.E., Ross J.A., and Fearon K.C. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84 (1997) 196-197
15. Blay Y.J., Negrier S., Combaret V., Attali S., and Goillot E. Serum level of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 52 (1992) 3317-3322
16. Falconer J.S., Fearon K.C.H., Ross J.A., et al. Acute-phase protein response and survival of patients with pancreatic cancer. Cancer 75 (1995) 2077-2082
17. Reeds P.J., Fjeld C.R., and Jahoor F. Do the differences between the amino acid compositions of acute phase and muscle proteins have a bearing on nitrogen loss in traumatic states?. J Nutr 124 (1998) 906-910
18. Preston T., Slater C., McMillan D.C., Falconer J.S., Shenkin A., and Fearon K.C.H. Fibrinogen synthesis is elevated in fasted cancer patients with an acute-phase response. J Nutr 128 (1998) 1355-1360
19. Baumann H., and Gauldie J. The acute phase response. Immunology Today 15 (1994) 74-80
20. McMillan D.C., Slater C., Preston T., Falconer J.S., and Fearon K.C.H. Simultaneous measurement of albumin and fibrinogen synthetic rates in normal and fasted subjects. Nutrition 12 (1996) 602-607
21. Slater C., Preston T., McMillan D.C., Falconer J.S., and Fearon K.C.H. GC/MS analysis of [2H5]-phenylalanine at very low enrichment: measurement of protein synthesis in health and disease. J Mass Spectrom 30 (1995) 1325-1332
22. Heymsfield S.B., McManus C., Smith J., Stevens V., and Nixon D.W. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr 36 (1982) 680-690
23. Retzlaff J.A., Tauxe W.N., Kiely J.M., and Stroebel C.F. Erythrocyte volume, plasma volume, and lean body mass in adult men and women. Blood 33 (1969) 649-661
24. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
25. Mayer G., and Schomerus H. Synthesis rates of albumin and fibrinogen in patients with cardiac and pulmonary cachexia. Acta Hepatogastroenterol (Stuttg) 24 (1977) 82-85
26. Morrison W.L., Gibson J.N., and Rennie M.J. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched-chain amino acid administration. Eur J Clin Invest 18 (1988) 648-654
27. Fearon K.C., Barber M.D., Falconer J.S., McMillan D.C., Ross J.A., and Preston T. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 23 (1999) 584-588
28. Ebrahimi B., Tucker S.L., Li D., Abbruzzese J.L., and Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101 (2004) 2727-2736
29. McMillan D.C., Preston T., Watson W.S., et al. Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer. Br J Surg 81 (1994) 1011-1014
30. Fearon K.C., McMillan D.C., Preston T., Winstanley F.P., Cruickshank A.M., and Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 213 (1991) 26-31
31. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem J 265 (1990) 621-636
32. Preston T., Slater C., McMillan D.C., Falconer J.S., Shenkin A., and Fearon K.C. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr 128 (1998) 1355-1360
33. Norrelund H., Wiggers H., Halbirk M., et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med 260 (2006) 11-21
34. Cortes C.W., Thompson P.D., Moyna N.M., et al. Protein kinetics in stable heart failure patients. J Appl Physiol 94 (2003) 295-300
35. Anker S.D., Steinborn W., and Strassburg S. Cardiac cachexia. Ann Med 36 (2004) 518-529
36. Tracey K.J., Morgello S., Koplin B., et al. Metabolic effects of cachectin/tumour necrosis factor are modified by site of production: cachectin/tumour necrosis factor-secreting tumour in skeletal muscle induces chronic cachexia, while implantation in brain induces predominately acute anorexia. J Clin Invest 86 (1990) 2014-2024
37. Preston T., Fearon K.C.H., Robertson I., East B.W., and Calman K.C. Tissue loss during severe wasting in lung cancer patients. In: Ellis K.J., Yasumura S., and Morgan W.D. (Eds). In vivo body composition studies (1987), Institute of Physical Sciences in Medicine, London, UK 60-69
38. Grimble R.F. Nutrition and cytokine action. Nutr Res Rev 3 (1990) 193-210